Health Watch: Unfolding Developments in Pharma World
Published on: March 18, 2026, 10:26 a.m. | Source: Devdiscourse
The U.S. Federal Trade Commission is vigilantly monitoring pharmaceutical companies as significant patent cliffs approach, aiming to protect consumers from unfair pricing. Meanwhile, R1 Therapeutics steps into the scene with a hefty funding round and a crucial drug license, while global conflicts challenge the sustainability of medical supply chains.
